DENVER, CO—Transcatheter mitral valve replacement (TMVR) in patients with either failed annuloplasty rings or severe mitral annular calcification (MAC) is feasible in selected individuals who are at ...

It remains early days for transcatheter mitral-valve replacement (TMVR) as a minimally invasive way to treat severe, mitral regurgitation (MR), but it's even earlier days for TMVR as an endovascular ...

The HighLife Transcatheter Mitral Valve Replacement (TMVR) system achieves a 90% technical success rate and effectively eliminates leakage in 88% of high-risk patients, as a recent study has shown.

Overview The global Transcatheter Mitral Valve Replacement (TMVR) market is witnessing rapid expansion and is expected to grow at a strong CAGR of nearly 20% during the forecast period. The increasing ...

Abbott Laboratories has received approval for a mitral valve replacement that can be implanted without open-heart surgery. The U.S. Food & Drug Administration gave the OK for the North Chicago-based ...

Operators reported the initial success of a novel transcatheter technique for treating complex paravalvular leaks (PVLs) after transcatheter aortic valve replacement (TAVR) or transcatheter mitral ...

Edwards Lifesciences announced Thursday that the California company has completed three first-in-human implants of the company’s transcatheter mitral valve replacement system. But it is not the only ...

LOS GATOS, Calif., Oct. 23, 2024 /PRNewswire/ -- Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced today the first-in-human trans-septal implantations using the 28 Fr. (French) Luna™ ...

Paris, January 26, 2026 – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the ...